Myriad Genetics
MYGN
MYGN
233 hedge funds and large institutions have $3.05B invested in Myriad Genetics in 2016 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 101 increasing their positions, 72 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
58% less call options, than puts
Call options by funds: $6.6M | Put options by funds: $15.6M
Holders
233
Holding in Top 10
2
Calls
$6.6M
Puts
$15.6M
Top Buyers
| 1 | +$23.1M | |
| 2 | +$16.8M | |
| 3 | +$15.6M | |
| 4 |
JIM
Jupiter Investment Management
London,
United Kingdom
|
+$10.5M |
| 5 |
Millennium Management
New York
|
+$9.61M |
Top Sellers
| 1 | -$201M | |
| 2 | -$70.6M | |
| 3 | -$66.6M | |
| 4 |
SCM
Scopia Capital Management
New York
|
-$39.5M |
| 5 |
FMA
Fiduciary Management Associates
Chicago,
Illinois
|
-$17.4M |